Correlation Between Monopar Therapeutics and Longboard Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Longboard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Longboard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Longboard Pharmaceuticals, you can compare the effects of market volatilities on Monopar Therapeutics and Longboard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Longboard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Longboard Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Longboard Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monopar and Longboard is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Longboard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longboard Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Longboard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longboard Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Longboard Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Longboard Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 41.91 times more return on investment than Longboard Pharmaceuticals. However, Monopar Therapeutics is 41.91 times more volatile than Longboard Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Longboard Pharmaceuticals is currently generating about 0.15 per unit of risk. If you would invest 1,783 in Monopar Therapeutics on August 28, 2024 and sell it today you would earn a total of 157.00 from holding Monopar Therapeutics or generate 8.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Longboard Pharmaceuticals
Performance |
| Timeline |
| Monopar Therapeutics |
| Longboard Pharmaceuticals |
Monopar Therapeutics and Longboard Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Longboard Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Longboard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Longboard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longboard Pharmaceuticals will offset losses from the drop in Longboard Pharmaceuticals' long position.| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals | Monopar Therapeutics vs. Seres Therapeutics |
| Longboard Pharmaceuticals vs. Molecular Partners AG | Longboard Pharmaceuticals vs. MediciNova | Longboard Pharmaceuticals vs. Anebulo Pharmaceuticals | Longboard Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |